ArticleTranslational lung cancer research2023

A pilot study of anlotinib with third-generation epidermal growth factor receptor tyrosine kinase inhibitors in untreated

Ting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.